NO20010960L - Alginatkapsler til bruk ved behandling av hjernesvulster - Google Patents
Alginatkapsler til bruk ved behandling av hjernesvulsterInfo
- Publication number
- NO20010960L NO20010960L NO20010960A NO20010960A NO20010960L NO 20010960 L NO20010960 L NO 20010960L NO 20010960 A NO20010960 A NO 20010960A NO 20010960 A NO20010960 A NO 20010960A NO 20010960 L NO20010960 L NO 20010960L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- brain tumors
- alginate capsules
- alginate
- capsules
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
- A61K2035/128—Immunoprotecting barriers, e.g. jackets, diffusion chambers capsules, e.g. microcapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20010960A NO20010960L (no) | 1998-08-26 | 2001-02-26 | Alginatkapsler til bruk ved behandling av hjernesvulster |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO983911A NO983911D0 (no) | 1998-08-26 | 1998-08-26 | Alginatkapsler til bruk ved behandling av hjernesvulst |
PCT/NO1999/000266 WO2000012066A1 (en) | 1998-08-26 | 1999-08-25 | Alginate capsules for use in the treatment of brain tumour |
NO20010960A NO20010960L (no) | 1998-08-26 | 2001-02-26 | Alginatkapsler til bruk ved behandling av hjernesvulster |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20010960D0 NO20010960D0 (no) | 2001-02-26 |
NO20010960L true NO20010960L (no) | 2001-04-25 |
Family
ID=19902361
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO983911A NO983911D0 (no) | 1998-08-26 | 1998-08-26 | Alginatkapsler til bruk ved behandling av hjernesvulst |
NO20010960A NO20010960L (no) | 1998-08-26 | 2001-02-26 | Alginatkapsler til bruk ved behandling av hjernesvulster |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO983911A NO983911D0 (no) | 1998-08-26 | 1998-08-26 | Alginatkapsler til bruk ved behandling av hjernesvulst |
Country Status (16)
Country | Link |
---|---|
US (2) | US6926888B1 (no) |
EP (1) | EP1105100A1 (no) |
JP (1) | JP2002523445A (no) |
KR (1) | KR100699286B1 (no) |
CN (1) | CN1191823C (no) |
AU (1) | AU760433B2 (no) |
BR (1) | BR9913326A (no) |
CA (1) | CA2340325A1 (no) |
IL (2) | IL141501A0 (no) |
IS (1) | IS5855A (no) |
NO (2) | NO983911D0 (no) |
NZ (1) | NZ510167A (no) |
RU (1) | RU2229287C2 (no) |
TR (1) | TR200100583T2 (no) |
WO (1) | WO2000012066A1 (no) |
ZA (1) | ZA200101464B (no) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1053329T3 (da) * | 1998-02-03 | 2010-01-25 | Ct Disease Contr & Prevention | Rekombinant lipideret PsaA-protein, fremgangsmåder til fremstilling og anvendelse |
SE530184C2 (sv) * | 2005-12-23 | 2008-03-18 | Kjell Stenberg | Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater |
KR100969516B1 (ko) * | 2007-08-16 | 2010-07-09 | 경북대학교 산학협력단 | 세포 생존력 및 기능을 향상시키는 도우넛형 세포 캡슐의제조 방법 및 세포 치료적용 |
US9555007B2 (en) * | 2013-03-14 | 2017-01-31 | Massachusetts Institute Of Technology | Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989006692A1 (en) * | 1988-01-12 | 1989-07-27 | Genentech, Inc. | Method of treating tumor cells by inhibiting growth factor receptor function |
US5073491A (en) * | 1988-12-23 | 1991-12-17 | Hoffman-La Roche Inc. | Immobilization of cells in alginate beads containing cavities for growth of cells in airlift bioreactors |
US5459054A (en) * | 1989-12-05 | 1995-10-17 | Neocrin Company | Cells encapsulated in alginate containing a high content of a- l- guluronic acid |
US5166137A (en) | 1991-03-27 | 1992-11-24 | Nobipols Forskningsstiftelse | Guluronic acid polymers and use of same for inhibition of cytokine production |
WO1992019195A1 (en) | 1991-04-25 | 1992-11-12 | Brown University Research Foundation | Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products |
US5286495A (en) * | 1992-05-11 | 1994-02-15 | University Of Florida | Process for microencapsulating cells |
ATE172099T1 (de) | 1994-07-08 | 1998-10-15 | Baxter Int | Implantierte vorrichtung mit tumorzellen zur behandlung von krebs |
US6126936A (en) * | 1995-03-10 | 2000-10-03 | Biohybrid Technologies Llc | Microcapsules and composite microreactors for immunoisolation of cells |
US5854205A (en) * | 1995-10-23 | 1998-12-29 | The Children's Medical Center Corporation | Therapeutic antiangiogenic compositions and methods |
WO1997036495A1 (en) | 1996-04-03 | 1997-10-09 | The Rogosin Institute | Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof |
WO1997038707A1 (en) * | 1996-04-17 | 1997-10-23 | Cytotherapeutics, Inc. | Method and device for delivery of apoptosis-inducing molecules |
US6027721A (en) | 1996-05-20 | 2000-02-22 | Cytotherapeutics, Inc. | Device and method for encapsulated gene therapy |
DE19638745C2 (de) * | 1996-09-11 | 2001-05-10 | Schering Ag | Monoklonale Antikörper gegen die extrazelluläre Domäne des menschlichen VEGF - Rezeptorproteins (KDR) |
US6368612B1 (en) * | 1997-12-12 | 2002-04-09 | Biohybrid Technologies Llc | Devices for cloaking transplanted cells |
-
1998
- 1998-08-26 NO NO983911A patent/NO983911D0/no unknown
-
1999
- 1999-08-25 KR KR1020017002450A patent/KR100699286B1/ko not_active IP Right Cessation
- 1999-08-25 US US09/763,682 patent/US6926888B1/en not_active Expired - Fee Related
- 1999-08-25 NZ NZ510167A patent/NZ510167A/en unknown
- 1999-08-25 AU AU55389/99A patent/AU760433B2/en not_active Ceased
- 1999-08-25 CA CA 2340325 patent/CA2340325A1/en not_active Abandoned
- 1999-08-25 EP EP99941915A patent/EP1105100A1/en not_active Withdrawn
- 1999-08-25 CN CNB998114332A patent/CN1191823C/zh not_active Expired - Fee Related
- 1999-08-25 BR BR9913326A patent/BR9913326A/pt not_active Application Discontinuation
- 1999-08-25 RU RU2001107823A patent/RU2229287C2/ru not_active IP Right Cessation
- 1999-08-25 IL IL14150199A patent/IL141501A0/xx active IP Right Grant
- 1999-08-25 WO PCT/NO1999/000266 patent/WO2000012066A1/en active IP Right Grant
- 1999-08-25 TR TR200100583T patent/TR200100583T2/xx unknown
- 1999-08-25 JP JP2000567186A patent/JP2002523445A/ja active Pending
-
2001
- 2001-02-19 IL IL141501A patent/IL141501A/en not_active IP Right Cessation
- 2001-02-21 ZA ZA200101464A patent/ZA200101464B/en unknown
- 2001-02-22 IS IS5855A patent/IS5855A/is unknown
- 2001-02-26 NO NO20010960A patent/NO20010960L/no not_active Application Discontinuation
-
2005
- 2005-04-11 US US11/104,245 patent/US20050180960A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2002523445A (ja) | 2002-07-30 |
CN1191823C (zh) | 2005-03-09 |
IS5855A (is) | 2001-02-22 |
US20050180960A1 (en) | 2005-08-18 |
ZA200101464B (en) | 2002-05-21 |
WO2000012066A1 (en) | 2000-03-09 |
BR9913326A (pt) | 2001-05-15 |
CA2340325A1 (en) | 2000-03-09 |
AU5538999A (en) | 2000-03-21 |
NZ510167A (en) | 2003-09-26 |
US6926888B1 (en) | 2005-08-09 |
RU2229287C2 (ru) | 2004-05-27 |
NO983911D0 (no) | 1998-08-26 |
NO20010960D0 (no) | 2001-02-26 |
AU760433B2 (en) | 2003-05-15 |
EP1105100A1 (en) | 2001-06-13 |
IL141501A (en) | 2006-10-31 |
KR20010074851A (ko) | 2001-08-09 |
TR200100583T2 (tr) | 2001-06-21 |
KR100699286B1 (ko) | 2007-03-26 |
CN1320032A (zh) | 2001-10-31 |
IL141501A0 (en) | 2002-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20005864D0 (no) | Quinasoler til behandling av hjernesvulst | |
NO984431D0 (no) | FremgangsmÕte for behandling av smerte | |
GB9824436D0 (en) | Methods of treatment | |
NO20022087L (no) | Fremgangsmåte for behandling av diabetes | |
KR100510795B1 (en) | Compositions and Methods for the Treatment of Tumor | |
NO20015542D0 (no) | Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner | |
NO20005885L (no) | Kombinasjonsterapi for behandling av refraktær depresjon | |
NO20023482D0 (no) | Fremgangsmåte for behandling av stoffmisbruk | |
EP1175616A4 (en) | METHODS FOR DIAGNOSING AND TREATING METASTATIC PROSTATE TUMORS | |
HK1041827B (zh) | 用於治療雌激素依賴性疾病的化合物以及製備和使用上述化合物的方法 | |
EP1187604A4 (en) | CONNECTIONS AND METHODS FOR TREATING POST-TRAUMATIC STRESS FAILURES | |
AU8678501A (en) | Compositions and methods for the diagnosis and treatment of tumor | |
NO984446D0 (no) | FremgangsmÕte for behandling av smerte | |
IL141426A0 (en) | Compositions and methods for the treatment of tumor | |
IL143212A0 (en) | Compositions and methods for the treatment of tumor | |
HUP0101947A3 (en) | Combination for the treatment of tumors | |
NO994258L (no) | Anvendelse av levobupivakain for behandling av ansiktsmigrene | |
NO20010960L (no) | Alginatkapsler til bruk ved behandling av hjernesvulster | |
PL354412A1 (en) | L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases | |
NO20003481D0 (no) | FremgangsmÕte for behandling av COPD | |
PT1200447E (pt) | Oxazinocarbazoles para o tratamento de doencas do snc | |
AU2566201A (en) | Compounds and methods for the treatment of pain | |
GB2341099B (en) | Clinical table for treatment of the spine | |
HK1040933A1 (zh) | N-取代的氮雜二環烷衍生物在治療中樞神經系統疾病中的應用 | |
GB9828564D0 (en) | Materials and methods for the treatment and diagnosis of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |